Tag Archives: AUST-R

Monash BME2032 Work Integrated Learning (WIL) students

Monash BME 2032 (Biomedical industry based learning) enables students to apply discipline related knowledge to authentic, real-world situations in non-clinical, industry-focused work environments. It also provides opportunities to establish closer links between future graduates and industry partners. This summer, three … Continue reading

Posted in Choosing wisely, Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment

APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform

Abstract: PHAA Workshop – Complementary medicine and advertising reform Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment